A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions
A live-attenuated COVID vaccine could enrich the current vaccine portfolio. Here, Liu et al. engineer a live-attenuated SARS-CoV-2 vaccine candidate by deleting four viral accessory genes and show immunogenicity and protection in mice and hamsters.
| Published in: | Nature Communications |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2022-07-01
|
| Online Access: | https://doi.org/10.1038/s41467-022-31930-z |
